Literature DB >> 10825394

Bryostatin 1 induces prolonged activation of extracellular regulated protein kinases in and apoptosis of LNCaP human prostate cancer cells overexpressing protein kinase calpha.

J E Gschwend1, W R Fair, C T Powell.   

Abstract

Previously, we reported that 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced apoptosis of LNCaP human prostate cancer cells was accompanied by prolonged translocation of protein kinase C (PKC)alpha to non-nuclear membranes and that TPA-resistant LNCaP cells had down-regulated PKCalpha. Here we show that 10 nM bryostatin 1 induced transient membrane translocation and down-regulation of PKCalpha, prolonged translocation of PKCdelta and epsilon to non-nuclear membranes, and did not induce cell death but blocked TPA-induced apoptosis. To test the hypothesis that inhibition of TPA-induced apoptosis by bryostatin 1 was due to down-regulation of PKCalpha, we inducibly overexpressed PKCalpha in LNCaP cells. Overexpression of PKCalpha alone did not induce apoptosis, even in clones that contained much more membrane-bound, active PKCalpha than was observed in TPA-treated untransfected LNCaP cells. However, the addition of 10 nM bryostatin 1 to PKCalpha-overexpressing LNCaP cells did not yield down-regulation of PKCalpha and induced extensive apoptosis. Immunoblot analysis revealed that TPA induced prolonged hyperphosphorylation of Raf-1 and activation of extracellular-regulated/mitogen-activated protein kinases 1 and 2 in untransfected LNCaP cells, as did bryostatin 1 in PKCalpha-overexpressing cells. On the other hand, bryostatin 1 induced only transient hyperphosphorylation of Raf-1 and activation of extracellular-regulated/mitogen-activated protein kinases 1 and 2 in untransfected LNCaP cells. These results confirm a role of prolonged membrane-associated PKCalpha in PKC activator-mediated LNCaP apoptosis and suggest involvement of the mitogen-activated protein kinase pathway.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10825394

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  10 in total

1.  Comparison of transcriptional response to phorbol ester, bryostatin 1, and bryostatin analogs in LNCaP and U937 cancer cell lines provides insight into their differential mechanism of action.

Authors:  N Kedei; A Telek; A M Michalowski; M B Kraft; W Li; Y B Poudel; A Rudra; M E Petersen; G E Keck; P M Blumberg
Journal:  Biochem Pharmacol       Date:  2012-11-09       Impact factor: 5.858

2.  High PKC alpha and low E-cadherin expression contribute to high migratory activity of colon carcinoma cells.

Authors:  K Masur; K Lang; B Niggemann; K S Zanker; F Entschladen
Journal:  Mol Biol Cell       Date:  2001-07       Impact factor: 4.138

3.  The synthetic bryostatin analog Merle 23 dissects distinct mechanisms of bryostatin activity in the LNCaP human prostate cancer cell line.

Authors:  Noemi Kedei; Andrea Telek; Alexandra Czap; Emanuel S Lubart; Gabriella Czifra; Dazhi Yang; Jinqiu Chen; Tyler Morrison; Paul K Goldsmith; Langston Lim; Poonam Mannan; Susan H Garfield; Matthew B Kraft; Wei Li; Gary E Keck; Peter M Blumberg
Journal:  Biochem Pharmacol       Date:  2011-03-30       Impact factor: 5.858

4.  Some phorbol esters might partially resemble bryostatin 1 in their actions on LNCaP prostate cancer cells and U937 leukemia cells.

Authors:  Noemi Kedei; Emanuel Lubart; Nancy E Lewin; Andrea Telek; Langston Lim; Poonam Mannan; Susan H Garfield; Matthew B Kraft; Gary E Keck; Sofiya Kolusheva; Raz Jelinek; Peter M Blumberg
Journal:  Chembiochem       Date:  2011-05-03       Impact factor: 3.164

5.  Molecular modeling, total synthesis, and biological evaluations of C9-deoxy bryostatin 1.

Authors:  Gary E Keck; Yam B Poudel; Arnab Rudra; Jeffrey C Stephens; Noemi Kedei; Nancy E Lewin; Megan L Peach; Peter M Blumberg
Journal:  Angew Chem Int Ed Engl       Date:  2010-06-21       Impact factor: 15.336

6.  Bryostatin 1 inhibits phorbol ester-induced apoptosis in prostate cancer cells by differentially modulating protein kinase C (PKC) delta translocation and preventing PKCdelta-mediated release of tumor necrosis factor-alpha.

Authors:  Vivian A von Burstin; Liqing Xiao; Marcelo G Kazanietz
Journal:  Mol Pharmacol       Date:  2010-06-01       Impact factor: 4.436

7.  Bryostatin-1 causes radiosensitization of BMG-1 malignant glioma cells through differential activation of protein kinase-Cδ not evident in the non-malignant AA8 fibroblasts.

Authors:  Raghubendra Singh Dagur; Shashank Hambarde; Sudhir Chandna
Journal:  Mol Cell Biochem       Date:  2014-12-04       Impact factor: 3.396

8.  Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases.

Authors:  Lijing Li; Ludmila Krymskaya; Jianbin Wang; Jill Henley; Anitha Rao; Lan-Feng Cao; Chy-Anh Tran; Monica Torres-Coronado; Agnes Gardner; Nancy Gonzalez; Kenneth Kim; Pei-Qi Liu; Ursula Hofer; Evan Lopez; Philip D Gregory; Qing Liu; Michael C Holmes; Paula M Cannon; John A Zaia; David L DiGiusto
Journal:  Mol Ther       Date:  2013-04-16       Impact factor: 11.454

9.  Mitogen Activated Protein kinase signal transduction pathways in the prostate.

Authors:  Paul D Maroni; Sweaty Koul; Randall B Meacham; Hari K Koul
Journal:  Cell Commun Signal       Date:  2004-06-25       Impact factor: 5.712

10.  JNK interacting protein 1 (JIP-1) protects LNCaP prostate cancer cells from growth arrest and apoptosis mediated by 12-0-tetradecanoylphorbol-13-acetate (TPA).

Authors:  T Ikezoe; Y Yang; H Taguchi; H P Koeffler
Journal:  Br J Cancer       Date:  2004-05-17       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.